Extrahepatic manifestations of chronic hepatitis C virus infection

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Therapeutic Advances in Infectious Disease

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/2049936115585942PMID 26862398PMCID PMC4735500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants.

  2017cited by this paper
• CAROTID ATHEROSCLEROSIS

  2016cited by this paper
• Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B‐cell non‐Hodgkin lymphomas, ANRS HC‐13 lympho‐C study

  2015cited by this paper
• PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.

  2015cited by this paper
• B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins.

  2014cited by this paper
• Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients

  2014cited by this paper
• Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis

  2014influential reference
• EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

  2014cited by this paper
• The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C.

  2014cited by this paper
• Hepatitis C virus infection in Egyptian children with type 1 diabetes mellitus: A single center study

  2014cited by this paper
• Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study.

  2014cited by this paper
• Active at night, sleepy all day--sleep disturbances in patients with hepatitis C virus infection.

  2014cited by this paper
• Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms.

  2014cited by this paper
• Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.

  2014influential reference
• Using Rituximab Plus Fludarabine and Cyclophosphamide as a Treatment for Refractory Mixed Cryoglobulinemia Associated With Lymphoma

  2013cited by this paper
• Kinetic Profiles and Management of Hepatitis B Virus Reactivation in Patients With Immune‐Mediated Inflammatory Diseases

  2013cited by this paper
• EASL Clinical Practice Guidelines: Management of hepatitis C virus infection European Association for the Study of the Liver ⇑

  2013cited by this paper
• Myocardial injury in patients with chronic hepatitis C infection.

  2013cited by this paper
• Interferon‐based therapy reduces risk of stroke in chronic hepatitis C patients: a population‐based cohort study in Taiwan

  2013cited by this paper
• Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.

  2013cited by this paper
• Life-Threatening Cryoglobulinemic Patients With Hepatitis C

  2013cited by this paper
• The impact of chronic hepatitis C on resource utilisation and in‐patient mortality for Medicare beneficiaries between 2005 and 2010

  2013cited by this paper
• Renal involvement in HCV-related vasculitis.

  2013cited by this paper
• Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia

  2013cited by this paper
• Hepatitis C virus-induced vasculitis: therapeutic options

  2013cited by this paper
• Hepatitis C Virus Infection and Risk of Stroke: A Systematic Review and Meta-Analysis

  2013cited by this paper
• Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis.

  2013influential reference
• Cryoglobulinemia vasculitis: an update

  2013influential reference
• Infection as a cause of type 1 diabetes?

  2012cited by this paper
• Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis.

  2012cited by this paper
• Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection.

  2012cited by this paper
• Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations

  2012cited by this paper
• A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.

  2012cited by this paper
• Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C

  2012cited by this paper
• A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.

  2012cited by this paper
• Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection

  2012cited by this paper
• Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study.

  2012influential reference
• Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition.

  2012cited by this paper
• Natural history of acute and chronic hepatitis C.

  2012cited by this paper
• HCV and Lymphoproliferation

  2012cited by this paper
• A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

  2011influential reference
• Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors.

  2011cited by this paper
• Early effect of peginterferon alpha-2b plus ribavirin treatment on blood pressure and insulin resistance in patients with chronic hepatitis C.

  2011cited by this paper
• Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis.

  2011cited by this paper
• Hepatitis C Virus-Related Lymphomagenesis in a Mouse Model

  2011cited by this paper
• Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real‐life, observational study

  2011cited by this paper
• All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population.

  2011cited by this paper
• Increased mortality among persons infected with hepatitis C virus.

  2011cited by this paper
• HCV infection and the incidence of CKD.

  2011influential reference
• Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.

  2011cited by this paper
• Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.

  2010cited by this paper
• Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.

  2010cited by this paper
• Investigating health‐related quality of life, mood and neuropsychological test performance in a homogeneous cohort of Irish female hepatitis C patients

  2010cited by this paper
• Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study.

  2010cited by this paper
• Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

  2010cited by this paper
• Hepatitis C virus RNA localization in human carotid plaques.

  2010cited by this paper
• Hepatitis C and carotid atherosclerosis: a retrospective analysis.

  2010cited by this paper
• Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo.

  2010cited by this paper
• Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.

  2010cited by this paper
• Lack of association between hepatitis C infection and chronic kidney disease.

  2010cited by this paper
• Pegylated‐interferon plus ribavirin for HCV‐positive indolent non‐Hodgkin lymphomas

  2009cited by this paper
• Infection, its treatment and the risk for stroke.

  2009cited by this paper
• Role of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular Damage1

  2009cited by this paper
• Increased rate of death related to presence of viremia among hepatitis C virus antibody–positive subjects in a community‐based cohort study

  2009cited by this paper
• Kidney diseases in HIV/HCV-co-infected patients

  2009cited by this paper
• Infection and type 1 diabetes mellitus - a two edged sword?

  2009cited by this paper
• Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV–hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study

  2009cited by this paper
• Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data

  2009cited by this paper
• KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease.

  2008cited by this paper
• Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis

  2008cited by this paper
• Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.

  2008cited by this paper
• Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia?

  2008cited by this paper
• The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis

  2008influential reference
• Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.

  2008cited by this paper
• The B lymphocyte stimulator receptor–ligand system in hepatitis C virus-induced B cell clonal disorders

  2008cited by this paper
• Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?

  2008cited by this paper
• Hepatitis C virus infection and the risk of coronary disease.

  2008cited by this paper
• Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis

  2008cited by this paper
• Cognitive Dysfunction in Chronic Hepatitis C: A Review

  2008cited by this paper
• Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.

  2008cited by this paper
• Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia.

  2008cited by this paper
• KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease

  2008cited by this paper
• Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.

  2007cited by this paper
• Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).

  2007cited by this paper
• Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.

  2007cited by this paper
• Improved cognitive function as a consequence of hepatitis C virus treatment *

  2007cited by this paper
• Hepatitis C virus lymphotropism: lessons from a decade of studies.

  2007cited by this paper
• HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques.

  2007cited by this paper
• Hepatitis C virus infection and the prevalence of renal insufficiency.

  2007cited by this paper
• The effects of HCV infection and management on health‐related quality of life

  2007cited by this paper
• Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C.

  2007cited by this paper
• Fatigue and Health-Related Quality of Life (HRQL) in Chronic Hepatitis C Virus Infection

  2007influential reference
• Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach.

  2007cited by this paper
• Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient.

  2007cited by this paper
• Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?

  2007cited by this paper
• Hepatitis C Virus and Risk of Lymphoma and Other Lymphoid Neoplasms: A Meta-analysis of Epidemiologic Studies

  2006cited by this paper
• Depression, anemia and health-related quality of life in chronic hepatitis C.

  2006cited by this paper
• Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment

  2006cited by this paper
• Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment

  2006cited by this paper
• Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition?

  2006cited by this paper

• Short-Term Clinical and Immunologic Outcomes Conditional on SVR12 in Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Treated With Direct-Acting Antivirals: A Systematic Review and Meta-Analysis

  2026cites this paper
• Effect of Direct-Acting Antiviral Therapy on Glycemic Control in Patients with Chronic Hepatitis C and Type 2 Diabetes: A Systematic Review and Meta-Analysis.

  2026cites this paper
• Retrospective study on the clinical characteristics of extrahepatic manifestations in hepatitis B virus-infected patients and their association with prognosis

  2026cites this paper
• Overcoming barriers to HCV screening in Latin America: from evidence to action.

  2026cites this paper
• Service provider perceptions of incorporating hepatitis C testing technologies into standard practice: Considerations for widespread implementation and scale-up.

  2026cites this paper
• Challenges in the Diagnosis of Autoimmune Hepatitis in Patients With Chronic Viral Hepatitis C: A Case Series and Review of the Literature

  2025cites this paper
• Impact of Direct-Acting Antivirals on Extrahepatic Manifestations in Chronic Hepatitis C: A Narrative Review with a Hermeneutic Approach

  2025cites this paper
• The global prevalence of co-occurrence of Sjögren syndrome and Hepatitis C virus infection: A systematic review and meta-analysis

  2025cites this paper
• Advances, challenges and future applications of liver organoids in experimental regenerative medicine

  2025cites this paper
• Oral manifestations in patients with chronic hepatitis C

  2025cites this paper
• Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes

  2025cites this paper
• Impact of HCV cure on systemic inflammation and bone density, quality, and turnover

  2025cites this paper
• STUDY OF THE ОRAL CAVITY AND DETERMINATION OF THE LEVEL OF PRO-INFLAMMATORY IL-2 AND ɤ-INF IN ORAL FLUID OF PATIENTS WITH VIRAL HEPATITIS C BEFORE AND AFTER COMPLEX TREATMENT

  2025cites this paper
• The Role of Viral Infections in Acute Kidney Injury and Mesenchymal Stem Cell-Based Therapy

  2025cites this paper
• Reviewing the Uncommon Extrahepatic Central Nervous System (CNS) Manifestations of Hepatitis C Virus (HCV) Infection: A Case Report

  2025cites this paper
• Cognitive Impairments in Viral Hepatitis Patients: Causes, Manifestations, and Impact on Quality of Life

  2025cites this paper
• Review of the mechanism of infection induced cerebral small vessel disease

  2025cites this paper
• Chronic leg ulcers in a patient with filarial lymphedema, varicose veins and hepatitis C virus infection: Healing with local wound management and supportive care

  2025influential citation
• RETRACTED ARTICLE: Awareness and infection prevention practices of hepatitis B virus among informal caregivers in public hospitals of Addis Ababa, Ethiopia, 2024: a cross-sectional study

  2025cites this paper
• Direct-acting antivirals (DAA) positively affect depression and cognitive function in patients with chronic hepatitis C

  2025cites this paper
• Assessing Quality of Life in Hepatitis C Patients: Improvements Following Direct-Acting Antiviral Therapy—A Single-Center Romanian Study

  2025cites this paper
• Chronic Hepatitis C in the Direct-Acting Antivirals Era: Carcinogenesis and Clinical Implications

  2025cites this paper
• Seroprevalence of Hepatitis C Virus and Factors Associated with It in Armenia, 2021

  2024cites this paper
• Efficacy and safety of glecaprevir and pibrentasvir in Saudi patients with chronic hepatitis C virus infection at a major tertiary hospital

  2024cites this paper
• Extrahepatic Manifestations of Chronic Hepatitis C Virus (HCV) Infection

  2024cites this paper
• Assessment of hepatitis c core antigen in epithelial salivary gland neoplasms (ex-vivo study)

  2024cites this paper
• HIV and hepatitis C virus-related misinformation may contribute to rising rates of infection and suboptimal clinical outcomes among persons with substance use

  2024cites this paper
• Renal Manifestations of Chronic Hepatitis C: A Review

  2024cites this paper
• Contemporary Insights into Hepatitis C Virus: A Comprehensive Review

  2024cites this paper
• Awareness and infection prevention practices of hepatitis B virus among informal caregivers in public hospitals of Addis Ababa, Ethiopia, 2024

  2024cites this paper
• Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.

  2024cites this paper
• Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals

  2024influential citation
• Post-Treatment Occurrence of Serum Cryoglobulinemia in Chronic Hepatitis C Patients

  2024cites this paper
• Impact of distinct antiviral treatment regimens on the long-term outcome after HCV cure – Data from the German Hepatitis C-Registry (DHC-R)

  2024cites this paper
• Unveiling the link: hepatitis C virus and Parkinson’s disease

  2024cites this paper
• Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals

  2024cites this paper
• EASL position paper on clinical follow-up after HCV cure.

  2024cites this paper
• The illness trap: The impact of disability benefits on willingness to receive HCV treatment.

  2024cites this paper
• Treatment of HCV with direct-acting antivirals on reducing mortality related to extrahepatic manifestations: a large population-based study in British Columbia, Canada

  2023cites this paper
• A multicentric and nationwide predictive study role of T cell sub‐population in the prevalence and prognosis of cryoglobulinemia among genotype 4 chronic hepatitis C patients

  2023cites this paper
• Improvement of carotid atherosclerosis and peripheral artery disease after hepatitis C virus eradication by direct-acting antivirals

  2023cites this paper
• Reflected Shadows of Chronic Hepatitis C Virus Infection on its Victims Undergoing Coronary Artery Bypass Grafting Surgery: 10-Years’ Experience

  2023cites this paper
• The impact of concomitant hepatitis C virus infection on liver and cardiovascular risks in patients with metabolic-associated fatty liver disease

  2023cites this paper
• Effectiveness of direct-acting antiviral (DAA) agents on hepatitis C virus-related mixed cryoglobulinemia syndrome: One-year follow-up

  2023cites this paper
• Prevalence of hepatitis C virus among patients with arthralgia: is it logic for screening?

  2023cites this paper
• A Framework to Overcome Challenges in the Management of Infections in Patients with Systemic Lupus Erythematosus

  2023cites this paper
• Gender-Specific Differences in Serum Sphingomyelin Species in Patients with Hepatitis C Virus Infection—Sphingomyelin Species Are Related to the Model of End-Stage Liver Disease (MELD) Score in Male Patients

  2023cites this paper
• Exploring Knowledge and Awareness of HCV Infection and Screening Test: A Cross-Sectional Survey Among an Italian Sample

  2023cites this paper
• The impact of HCV chronic positivity and clearance on extrahepatic morbidity in thalassemia major patients: an observational study from MIOT Network.

  2023cites this paper
• Challenges Facing Viral Hepatitis C Elimination in Lebanon

  2023cites this paper
• CLEC18A Impairs Phagocytosis by Reducing FcγRIIA Expression and Arresting Autophagosome-Lysosome Fusion

  2023cites this paper
• Assessment of the influence of vitamin D level on the course of chronic hepatitis C in comorbidity with chronic pancreatitis

  2023cites this paper
• Cardioprotective effect of antiviral therapy among hepatitis C infected patients: A meta-analysis

  2023cites this paper
• Hepatitis C Virus (HCV) Infection and Neurocognitive Impairment in Subjects with Mild Liver Disease

  2023cites this paper
• Arthralgien bei Psoriasis vulgaris – manchmal lohnt ein zweiter Blick

  2023cites this paper
• Onset of Oral Lichen Planus Led to Direct-Acting Antiviral Therapy in a Patient with Long-Term Hepatitis C: The Role of a Dentist as Gatekeeper

  2023cites this paper
• Low risk of viral hepatitis amongst patients with severe mental disorders

  2023cites this paper
• Risk of Parkinson’s disease in hepatitis B and C populations: a systematic review and meta-analysis

  2023cites this paper
• Malignancy and viral infections in Sub-Saharan Africa: A review

  2023cites this paper
• Effect of Educational Nursing Interventions Program on the Severity of Extrahepatic Manifestations among Patients with Chronic Hepatitis C Virus

  2022influential citation
• Transient flare of psoriasis under direct‐acting antiviral therapy of chronic hepatitis C: A case report

  2022cites this paper
• Disparities in the quality of care for chronic hepatitis C among Medicare beneficiaries

  2022cites this paper
• Predictive value of P300 event-related potential component in early cognitive impairment in patients with uncomplicated newly diagnosed hepatitis C virus

  2022cites this paper
• Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?

  2022cites this paper
• Severe Autoimmune Hemolytic Anemia Complicating Treatment-naive Chronic Hepatitis C Infection: A Case Report.

  2022cites this paper
• Therapeutic Advances in Viral Hepatitis A–E

  2022cites this paper
• Hepatitis C Positive Patients in Relation to Polyclonal and Monoclonal Gammopathy: An Egyptian Experience

  2022cites this paper
• Splenic Marginal Zone Lymphoma in a Chronic Hepatitis B Patient: A Rare Case Report and a Literature Review

  2022cites this paper
• KDIGO 2022 Clinical Practice Guideline FOR the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

  2022cites this paper
• ASSESSMENT OF COLON MICROBIOCENOSIS DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS C.

  2022cites this paper
• Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals

  2022cites this paper
• Extrahepatic factors in hepatic immune regulation

  2022cites this paper
• Chronic hepatitis C in hemodialysis patients: Prevalence and liver fibrosis impact in the National Center for Renal Health in Peru

  2022cites this paper
• Virological failures of primary interferon-free therapy in patients with chronic HCV RNA viremia and successful repeated interferon-free therapy

  2022cites this paper
• World Journal of Meta-Analysis

  2022cites this paper
• COVID-19 AND THE THYROID FUNCTION IN PATIENTS WITH HCV- ASSOCIATED HEPATOCELLULAR CARCINOMA.

  2022cites this paper
• Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents.

  2022cites this paper
• Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—From Drug Discovery to Successful Implementation in Clinical Practice

  2022cites this paper
• Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients

  2022cites this paper
• Effects of direct‐acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real‐life Italian experience

  2022cites this paper
• Ein umfassendes Screening auf Hepatitis B und C ist eine effektive Krebsprävention und die Voraussetzung für die Elimination dieser Infektionen – Daten und Anmerkungen zu einer Diskussion

  2022cites this paper
• КОМПЛЕКСНА ТЕРАПІЯ ХРОНІЧНОГО ПАНКРЕАТИТУ, КОМОРБІДНОГО З ХРОНІЧНИМ ВІРУСНИМ ГЕПАТИТОМ С, ІЗ ЗАСТОСУВАННЯМ БІОРЕГУЛЯЦІЙНОЇ ТЕРАПІЇ

  2022cites this paper
• The Effect of Multiple Imputation of Routine Pathology Variables on Laboratory Diagnosis of Hepatitis C Infection

  2022cites this paper
• Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients

  2022cites this paper
• ASEPTIC MENINGITIS AS AN EXTRAHEPATIC MANIFESTATION OF HEPATITIS C: A CLINICAL CASE PRESENTATIONIN A WHITE YOUNG FEMALE EUROPEAN ADULT.

  2022cites this paper
• Propensity Score Modeling in Electronic Health Records with Time-to-Event Endpoints: Application to Kidney Transplantation

  2022cites this paper
• Another Step Toward Hepatitis C Elimination: An Economic Evaluation of an Irish National Birth Cohort Testing Program.

  2022cites this paper
• Viral hepatitis: A narrative review of hepatitis A–E

  2022cites this paper
• Direct‑acting antiviral treatment decreases serum undercarboxylated osteocalcin in male patients with chronic hepatitis C.

  2022cites this paper
• The impact of COVID 19 infection on HCV-induced thyroid disease.

  2021cites this paper
• Features of Lipid Metabolism in HCV Infection

  2021cites this paper
• A Prospective Observational Study of 42 Patients with COVID-19 infection and a History of Hepatitis C Virus Infection and Thyroid Disease with Follow-Up Thyroid Function and Autoantibody Testing

  2021cites this paper
• Musculoskeletal Manifestations and Bone Mineral Density in Chronic Hepatitis C Patients

  2021cites this paper
• The impact of HCV eradication on hyperglycemia, insulin resistance, cytokine production, and insulin receptor substrate-1 and 2 expression in patients with HCV infection

  2021cites this paper
• Distinct Microbial Communities in Dilated Cardiomyopathy Explanted Hearts Are Associated With Different Myocardial Rejection Outcomes

  2021cites this paper
• A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy

  2021cites this paper
• Impact of direct acting antivirals (DAA) on neurologic disorders in chronic hepatitis C.

  2021cites this paper
• Autoantibodies and Rheumatologic Manifestations in Hepatitis C Virus Infection

  2021cites this paper
• Direct-Acting Antiviral Therapy Effect on Extrahepatic Rheumatic Manifestations in Egyptian Chronic Hepatitis C (HCV) Patients

  2021influential citation
• Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor

  2021cites this paper